Anti-HIV and Anti-Hepatitis C Virus Drugs Inhibit P-Glycoprotein Efflux Activity in Caco-2 Cells and Precision-Cut Rat and Human Intestinal Slices.


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
11 2019
Historique:
received: 03 05 2019
accepted: 30 08 2019
pubmed: 5 9 2019
medline: 20 8 2020
entrez: 5 9 2019
Statut: epublish

Résumé

P-glycoprotein (ABCB1), an ATP-binding-cassette efflux transporter, limits intestinal absorption of its substrates and is a common site of drug-drug interactions (DDIs). ABCB1 has been suggested to interact with many antivirals used to treat HIV and/or chronic hepatitis C virus (HCV) infections. Using bidirectional transport experiments in Caco-2 cells and a recently established

Identifiants

pubmed: 31481446
pii: AAC.00910-19
doi: 10.1128/AAC.00910-19
pmc: PMC6811448
pii:
doi:

Substances chimiques

ATP Binding Cassette Transporter, Subfamily B, Member 1 0
Anti-HIV Agents 0
Antiviral Agents 0
Benzimidazoles 0
Carbamates 0
Fluorenes 0
Imidazoles 0
Pyrrolidines 0
ledipasvir 013TE6E4WV
Lopinavir 2494G1JF75
Zidovudine 4B9XT59T7S
Atazanavir Sulfate 4MT4VIE29P
Valine HG18B9YRS7
Saquinavir L3JE09KZ2F
daclatasvir LI2427F9CI
Maraviroc MD6P741W8A
Ritonavir O3J8G9O825

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

J Antimicrob Chemother. 2011 Sep;66(9):2107-11
pubmed: 21680580
J Antimicrob Chemother. 2007 Feb;59(2):238-45
pubmed: 17202245
Drug Metab Dispos. 2008 Jul;36(7):1249-54
pubmed: 18378562
J Pharm Sci. 2009 Nov;98(11):4413-9
pubmed: 19472342
Clin Pharmacol Ther. 2013 Jul;94(1):3-9
pubmed: 23778703
PLoS One. 2015 Oct 21;10(10):e0141164
pubmed: 26488159
Clin Pharmacol Ther. 2018 Nov;104(5):890-899
pubmed: 30091177
P T. 2015 Apr;40(4):256-76
pubmed: 25859119
Drug Metab Dispos. 2006 May;34(5):786-92
pubmed: 16455806
Drug Metab Dispos. 2018 Aug;46(8):1212-1225
pubmed: 29695614
Clin Pharmacokinet. 2018 Aug;57(8):911-928
pubmed: 29353349
HIV Clin Trials. 2018 Feb;19(1):1-7
pubmed: 29179644
Biol Pharm Bull. 2000 Dec;23(12):1528-31
pubmed: 11145192
Mol Pharmacol. 2001 Apr;59(4):806-13
pubmed: 11259625
Drug Metab Dispos. 2006 Nov;34(11):1893-902
pubmed: 16914511
Nat Rev Drug Discov. 2010 Mar;9(3):215-36
pubmed: 20190787
Mol Pharm. 2014 Oct 6;11(10):3547-55
pubmed: 25158075
PLoS One. 2012;7(3):e33253
pubmed: 22470447
Antimicrob Agents Chemother. 2007 Oct;51(10):3498-504
pubmed: 17664327
Reprod Toxicol. 2018 Aug;79:57-65
pubmed: 29859254
Antivir Ther. 2007;12(2):267-72
pubmed: 17503669
PLoS One. 2011 Feb 23;6(2):e16800
pubmed: 21373194
Antivir Ther. 2009;14(5):607-18
pubmed: 19704163
Drug Metab Dispos. 2011 Jul;39(7):1196-202
pubmed: 21447733
Drug Metab Pharmacokinet. 2013;28(2):144-52
pubmed: 22971642
Drug Metab Dispos. 2007 Mar;35(3):340-4
pubmed: 17172311
Drug Metab Dispos. 2005 Jun;33(6):764-70
pubmed: 15764714
Clin Pharmacol Ther. 2008 Jul;84(1):75-82
pubmed: 18183034
AIDS. 2014 Jan 2;28(1):9-17
pubmed: 24413260
Drug Metab Dispos. 2017 Apr;45(4):353-360
pubmed: 28153842
Pharmaceutics. 2016 Apr 12;8(2):null
pubmed: 27077878
Clin Infect Dis. 2012 Jul;55 Suppl 1:S3-9
pubmed: 22715211
Drug Metab Dispos. 2019 Sep;47(9):954-960
pubmed: 31266750
J Clin Invest. 1998 Jan 15;101(2):289-94
pubmed: 9435299
Infect Dis Ther. 2015 Jun;4(2):159-72
pubmed: 25896480
J Antimicrob Chemother. 2010 Aug;65(8):1672-80
pubmed: 20551216
J Pharm Biomed Anal. 2018 Jan 5;147:378-399
pubmed: 29031512
Antivir Ther. 2005;10(5):645-55
pubmed: 16152758
Nat Protoc. 2010 Sep;5(9):1540-51
pubmed: 20725069
Fundam Clin Pharmacol. 2014 Feb;28(1):65-77
pubmed: 22913740
J Infect Dis. 2007 Aug 15;196 Suppl 1:S63-75
pubmed: 17624828
CNS Spectr. 2019 Jun;24(3):287-312
pubmed: 30295215
AIDS. 2012 Jul 31;26 Suppl 1:S39-53
pubmed: 22781176
Pharm Res. 2002 Oct;19(10):1400-16
pubmed: 12425456
J Pharm Sci. 2009 Dec;98(12):4914-27
pubmed: 19373887
J Pharm Sci. 2017 Sep;106(9):2312-2325
pubmed: 28414144
Cancer Treat Rev. 2009 Apr;35(2):137-47
pubmed: 18986769
Antivir Ther. 2010;15(3):413-23
pubmed: 20516560
Int J Pharm. 2007 Jul 18;339(1-2):139-47
pubmed: 17451894
Trends Pharmacol Sci. 2010 Jan;31(1):22-35
pubmed: 20004485
Reprod Toxicol. 2015 Nov;57:176-82
pubmed: 26169552
Eur J Pharm Biopharm. 2012 Oct;82(2):340-51
pubmed: 22906709
Clin Pharmacokinet. 2016 Feb;55(2):197-208
pubmed: 26353895
AIDS. 2001 Mar 9;15(4):483-91
pubmed: 11242145
Drug Metab Dispos. 2010 Sep;38(9):1407-10
pubmed: 20551242
J Pharm Biomed Anal. 2018 Jan 5;147:400-416
pubmed: 28755849
Hepatology. 2015 Sep;62(3):932-54
pubmed: 26111063
Biochem Pharmacol. 2007 May 15;73(10):1573-81
pubmed: 17328866
J Pharmacol Exp Ther. 1999 Apr;289(1):149-55
pubmed: 10086998
AAPS J. 2013 Jul;15(3):629-45
pubmed: 23543602
Biopharm Drug Dispos. 2017 Mar;38(2):127-138
pubmed: 27757966
J Antimicrob Chemother. 2010 Nov;65(11):2319-28
pubmed: 20817741
J Infect Dis. 2008 Oct 1;198(7):948-61
pubmed: 18713054
J Acquir Immune Defic Syndr. 2018 Aug 1;78(4):465-472
pubmed: 29649076
Pharmaceutics. 2011 Oct 21;3(4):745-81
pubmed: 24309307
Toxicol In Vitro. 2015 Aug;29(5):1070-8
pubmed: 25917215
Mol Pharmacol. 1997 May;51(5):741-54
pubmed: 9145912
Drug Metab Dispos. 2009 Sep;37(9):1956-62
pubmed: 19505989
Eur J Pharm Sci. 2006 Nov;29(3-4):269-77
pubmed: 16822659
Cancer Res. 2001 Sep 15;61(18):6635-9
pubmed: 11559526
J Antimicrob Chemother. 2011 Apr;66(4):802-12
pubmed: 21393174
Pharmacogenomics. 2011 Jul;12(7):1017-37
pubmed: 21787191
Mol Pharm. 2005 Jan-Feb;2(1):12-21
pubmed: 15804173
Biopharm Drug Dispos. 2016 Jan;37(1):28-38
pubmed: 26390406
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28696229
Eur J Pharmacol. 2008 Jan 28;579(1-3):104-9
pubmed: 18037401
Pharm Res. 2013 Apr;30(4):1050-64
pubmed: 23224979
Mol Pharm. 2017 May 1;14(5):1601-1609
pubmed: 28329446
Nat Protoc. 2007;2(9):2111-9
pubmed: 17853866

Auteurs

Ondrej Martinec (O)

Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.

Martin Huliciak (M)

Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.

Frantisek Staud (F)

Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic.

Filip Cecka (F)

Department of Surgery, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.

Ivan Vokral (I)

Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic vokral@faf.cuni.cz cervenyl@faf.cuni.cz.

Lukas Cerveny (L)

Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Hradec Kralove, Czech Republic vokral@faf.cuni.cz cervenyl@faf.cuni.cz.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH